Inlay

//

ProfilePosts

Dr. Peter Ch’en, MD, MPH 🎓🩺 Thank you @einsteinmededu.bsky.social for the experience of a lifetime - I’ll keep the lessons from the BX close. Catch me as a dermatologist *soon*! Back to Seattle @uwdermatology.bsky.social I go. To my community who kept me going - we did this together. Thank you.

Onwards and upwards! 💪🔬 research fuels scientific progress and innovation, so grateful to the Andy Hill CARE Fund in recognizing this 😊

Apr 9, 2025

23d

🚀 Exciting news! #MC3Institute is now on Bluesky! We’re a new institute dedicated to improving the lives of Merkel cell carcinoma #MCC patients through translational research. Follow us for updates, latest research, & collaboration opportunities. Learn more at mc3institute.uw.edu! #CancerResearch

Proud to share the #NghiemLab & #MC3Institute received a $1.3m grant from the Andy Hill Cancer Research Endowment #CAREFund to support 2 projects focused on advancing Merkel cell carcinoma #MCC research. 🔗 mc3institute.uw.edu/news/nghiem-lab-mc3-institute-awarded-1.3-million-cancer-research

Mar 20, 2025

Apr 9, 2025

Peter Ch’en

Get those blood tests (AMERK and ctDNA) going for MCC patients! Super helpful for surveillance and early recurrence detection, and provides a lot of peace of mind for both patients and clinicians. @mc3-institute.bsky.social @paulnghiem.bsky.social @lachancekrista.bsky.social

6mo

Merkel Cell Carcinoma Collaborative (MC3) Institute

Peter Ch’en

In this cohort study of Merkel cell #carcinoma patients, a falling or negative titer indicated a 99.3% chance of remaining recurrence-free over 3 months, while a rising oncoprotein antibody titer suggested a 58% risk of recurrence by 12 months. ja.ma/4rifJeA

6mo

JAMA Dermatology